M Douglas Winship - Net Worth and Insider Trading
M Douglas Winship Net Worth
The estimated net worth of M Douglas Winship is at least $1 Million dollars as of 2024-04-19. M Douglas Winship is the VP, Regulatory Operations of Catalyst Pharmaceuticals Inc and owns about 74,131 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $1 Million. Details can be seen in M Douglas Winship's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that M Douglas Winship has not made any transactions after 2015-10-23 and currently still holds the listed stock(s).
Transaction Summary of M Douglas Winship
M Douglas Winship Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, M Douglas Winship owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of M Douglas Winship’s form 4 insider trades.
Insider Ownership Summary of M Douglas Winship
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2015-10-23 | V.P. of Regulatory Operations |
M Douglas Winship Latest Holdings Summary
M Douglas Winship currently owns a total of 1 stock. M Douglas Winship owns 74,131 shares of Catalyst Pharmaceuticals Inc (CPRX) as of October 23, 2015, with a value of $1 Million.
Latest Holdings of M Douglas Winship
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2015-10-23 | 74,131 | 15.39 | 1,140,505 |
Holding Weightings of M Douglas Winship
M Douglas Winship Form 4 Trading Tracker
According to the SEC Form 4 filings, M Douglas Winship has made a total of 0 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 22,800 shares on October 23, 2015, which brought M Douglas Winship around $76,152.
Insider Trading History of M Douglas Winship
- 1
M Douglas Winship Trading Performance
GuruFocus tracks the stock performance after each of M Douglas Winship's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by M Douglas Winship is 90.36%. GuruFocus also compares M Douglas Winship's trading performance to market benchmark return within the same time period. The performance of stocks bought by M Douglas Winship within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how M Douglas Winship's insider trading performs compared to the benchmark.
Performance of M Douglas Winship
Average Return
5.2%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.65 | 90.36 | -27.81 | 5.2 | 39.88 | 43.44 |
| Relative Return to S&P 500(%) | -5.03 | 68.16 | -55.52 | -40.58 | 10.3 | 22.2 |
M Douglas Winship Ownership Network
Ownership Network List of M Douglas Winship
Ownership Network Relation of M Douglas Winship
M Douglas Winship Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
M Douglas Winship is the V.P. of Regulatory Operations of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Compliance/Legal Officer Brian Elsbernd , Chief Accounting Officer Alicia Grande , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, M Douglas Winship made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 430,000 shares made by Alicia Grande , a net sale of 105,000 shares made by David S Tierney , and a net sale of 89,666 shares made by Brian Elsbernd .
In summary, during the past 3 months, insiders sold 50,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 1,804,523 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,804,523 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
M Douglas Winship Mailing Address
Above is the net worth, insider trading, and ownership report for M Douglas Winship. You might contact M Douglas Winship via mailing address: 220 Miracle Mile, Suite 234, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
